NCT04205838 2026-02-27Anakinra in Preventing Severe Chimeric Antigen Receptor T-Cell Related Encephalopathy Syndrome in Patients With Recurrent or Refractory Large B-cell LymphomaJonsson Comprehensive Cancer CenterPhase 2 Terminated23 enrolled